Smilow Cancer Hospital at Yale-New Haven — New Haven, Connecticut

Smilow Cancer Hospital at Yale-New Haven is a clinical research site located in New Haven, Connecticut, United States 06511.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Smilow Cancer Hospital at Yale-New Haven has participated in 31 clinical trials with 5 currently active.

Therapeutic areas: Pancreatic Cancer Metastatic, Advanced Solid Tumors, Nonsquamous Nonsmall Cell Neoplasm of Lung.

Sponsors: Cornerstone Pharmaceuticals, Pfizer, OncoMed Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Smilow Cancer Hospital at Yale-New Haven?

Smilow Cancer Hospital at Yale-New Haven has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Smilow Cancer Hospital at Yale-New Haven conducted?

Smilow Cancer Hospital at Yale-New Haven has 31 clinical trials on record, with 5 currently active. Their work covers Pancreatic Cancer Metastatic, Advanced Solid Tumors, Nonsquamous Nonsmall Cell Neoplasm of Lung.

Is Smilow Cancer Hospital at Yale-New Haven accredited by Crixeo Health?

Yes — Smilow Cancer Hospital at Yale-New Haven holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Smilow Cancer Hospital at Yale-New Haven?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.